Danaher (DHR) October 25 weekly call option implied volatility into quarter results

Go back to Danaher (DHR) October 25 weekly call option implied volatility into quarter results

Danaher (DHR) PT Lowered to $277 at Baird

October 23, 2024 6:25 AM EDT

Baird analyst Catherine Schulte lowered the price target on Danaher (NYSE: DHR) to $277.00 (from $278.00) while maintaining a Outperform rating.

The analyst comments "Maintain Outperform rating, new $277 price target (-$1). DHR reported 3Q results ahead of expectations, driven by Biotechnology and Cepheid respiratory upside.... More

Danaher (DHR) PT Lowered to $275 at Leerink Partners

October 23, 2024 6:05 AM EDT

Leerink Partners analyst Puneet Souda lowered the price target on Danaher (NYSE: DHR) to $275.00 (from $280.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: We see DHR as the leader in the highly attractive, spec'd-in and recurring rev market of bioprocess tools,... More